Engineering the First Chimeric Antibody in Targeting Intracellular PRL-3 Oncoprotein for Cancer Therapy in Mice

Antibodies are considered as ‘magic bullets’ because of their high specificity. It is believed that antibodies are too large to routinely enter the cytosol, thus antibody therapeutic approach has been limited to extracellular or secreted proteins expressed by cancer cells. However, many oncogenic pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Ke, Tang, Jing Ping, Jie, Li, Al-Aidaroos, Abdul Qader O., Hong, Cheng William, Tan, Cheng Peow Bobby, Park, Jung Eun, Varghese, Leyon, Feng, Zhiwei, Zhou, Jianbiao, Chng, Wee Joo, Zeng, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2012
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326646/
https://www.ncbi.nlm.nih.gov/pubmed/22374986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326646/
https://www.ncbi.nlm.nih.gov/pubmed/22374986

Ejemplares similares